IκB/IKK
IKK (IκB kinase) is an enzyme complex that participates in NF-κB signaling pathway. It phosphorylates and inhibits IκB, thus leads to the activation of NF-κB. It is a target for treatment of inflammatory diseases and cancer.
-
A3485 IKK-2 inhibitor VIIISummary: IKK-2 inhibitor,potent and selective
-
A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe inhibitor
-
A4210 Bay 11-7821 (BAY 11-7082)1 CitationSummary: IKK/NF-κB/TNFα inhibitor
-
A4217 QNZ (EVP4593)2 CitationSummary: Potent NF-κB inhibitor
-
A3248 BMS345541 hydrochlorideTarget: IKKSummary: IKK inhibitor,highly selective
-
B1587 IMD 03541 CitationSummary: IKKβ inhibitor
-
B1585 SC-514Summary: ATP-competitive IKK-2 inhibitor, orally active
-
N1831 LuteolinTarget: AP-1|MMP|15-lipoxygenasesSummary: Antioxidant and free radical scavenger
-
N1846 Tanshinone IIATarget: AP-1|MAGLSummary: Antioxidant and anti-inflammatory reagent
-
A2604 CelastrolTarget: ProteasomeSummary: Antioxidant, anti-inflammatory and immunosuppressive agent